Wall Street brokerages forecast that DexCom, Inc. (NASDAQ:DXCM – Get Rating) will announce $619.85 million in sales for the current quarter, according to Zacks Investment Research. Nine analysts have provided estimates for DexCom’s earnings, with the lowest sales estimate coming in at $604.80 million and the highest estimate coming in at $629.03 million. DexCom posted […]
/PRNewswire/ The "Global Biosensors Market (2022-2027) by Type, Product, Application, Geography, Competitive Analysis, and the Impact of Covid-19 with.
DUBLIN (BUSINESS WIRE) The "Diabetes Devices Market Research Report by Type (Blood Glucose Monitoring and Insulin Delivery Devices), End Use, Distribution, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchA.